Receptor 5-HT5A (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Receptor 5-HT5A" in Polish language version.

refsWebsite

Global rank Polish rank

10nih.gov

4^th place

7^th place

7doi.org

2^nd place

6^th place

1aspetjournals.org

6,663^rd place

7,639^th place

1web.archive.org

1^st place

aspetjournals.org

molpharm.aspetjournals.org

Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, Muscatelli F, Mattei MG, Hen R. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. „Mol. Pharmacol.”. 43 (3), s. 313–9, 03-1993. PMID: 8450829. (ang.).

doi.org

Rees S, den Daas I, Foord S, Goodson S, Bull D, Kilpatrick G, Lee M. Cloning and characterisation of the human 5-HT5A serotonin receptor. „FEBS Lett.”. 355 (3), s. 242–6, December 1994. DOI: 10.1016/0014-5793(94)01209-1. PMID: 7988681. (ang.).
Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE. The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. „Eur. J. Pharmacol.”. 361 (2-3), s. 299–309, November 1998. DOI: 10.1016/S0014-2999(98)00744-4. PMID: 9865521. (ang.).
Nelson DL. 5-HT5 receptors. „Curr Drug Targets CNS Neurol Disord”. 3 (1), s. 53–8, 02-2004. DOI: 10.2174/1568007043482606. PMID: 14965244. (ang.).
Thomas DR, Soffin EM, Roberts C, Kew JN, de la Flor RM, Dawson LA, Fry VA, Coggon SA, Faedo S, Hayes PD, Corbett DF, Davies CH, Hagan JJ. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain. „Neuropharmacology”. 51 (3), s. 566–77, September 2006. DOI: 10.1016/j.neuropharm.2006.04.019. PMID: 16846620. (ang.).
Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L. Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration. „Bioorg. Med. Chem. Lett.”. 18 (1), s. 262–6, 01-2008. DOI: 10.1016/j.bmcl.2007.10.078. PMID: 18023344. (ang.).
Dietz BM, Mahady GB, Pauli GF, Farnsworth NR. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. „Brain Res. Mol. Brain Res.”. 138 (2), s. 191–7, August 2005. DOI: 10.1016/j.molbrainres.2005.04.009. PMID: 15921820. (ang.).
Wu J, Li Q, Bezprozvanny I. Evaluation of Dimebon in cellular model of Huntington's disease. „Mol Neurodegener”. 3 (1), s. 15, 2008. DOI: 10.1186/1750-1326-3-15. PMID: 18939977. (ang.).

nih.gov

ncbi.nlm.nih.gov

Entrez Gene: HTR5A 5-hydroxytryptamine (serotonin) receptor 5A. (ang.).
Rees S, den Daas I, Foord S, Goodson S, Bull D, Kilpatrick G, Lee M. Cloning and characterisation of the human 5-HT5A serotonin receptor. „FEBS Lett.”. 355 (3), s. 242–6, December 1994. DOI: 10.1016/0014-5793(94)01209-1. PMID: 7988681. (ang.).
Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE. The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. „Eur. J. Pharmacol.”. 361 (2-3), s. 299–309, November 1998. DOI: 10.1016/S0014-2999(98)00744-4. PMID: 9865521. (ang.).
Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, Muscatelli F, Mattei MG, Hen R. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. „Mol. Pharmacol.”. 43 (3), s. 313–9, 03-1993. PMID: 8450829. (ang.).
Nelson DL. 5-HT5 receptors. „Curr Drug Targets CNS Neurol Disord”. 3 (1), s. 53–8, 02-2004. DOI: 10.2174/1568007043482606. PMID: 14965244. (ang.).
Thomas DR, Soffin EM, Roberts C, Kew JN, de la Flor RM, Dawson LA, Fry VA, Coggon SA, Faedo S, Hayes PD, Corbett DF, Davies CH, Hagan JJ. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain. „Neuropharmacology”. 51 (3), s. 566–77, September 2006. DOI: 10.1016/j.neuropharm.2006.04.019. PMID: 16846620. (ang.).
Wesołowska A. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors. „Pol J Pharmacol”. 54 (4), s. 327–41, 2002. PMID: 12523486. (ang.).
Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L. Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration. „Bioorg. Med. Chem. Lett.”. 18 (1), s. 262–6, 01-2008. DOI: 10.1016/j.bmcl.2007.10.078. PMID: 18023344. (ang.).
Dietz BM, Mahady GB, Pauli GF, Farnsworth NR. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. „Brain Res. Mol. Brain Res.”. 138 (2), s. 191–7, August 2005. DOI: 10.1016/j.molbrainres.2005.04.009. PMID: 15921820. (ang.).
Wu J, Li Q, Bezprozvanny I. Evaluation of Dimebon in cellular model of Huntington's disease. „Mol Neurodegener”. 3 (1), s. 15, 2008. DOI: 10.1186/1750-1326-3-15. PMID: 18939977. (ang.).

web.archive.org

Wesołowska A. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors. „Pol J Pharmacol”. 54 (4), s. 327–41, 2002. PMID: 12523486. (ang.).